469 related articles for article (PubMed ID: 28970212)
1. Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis.
Maksymowych WP; Wichuk S; Dougados M; Jones HE; Pedersen R; Szumski A; Marshall L; Bukowski JF; Lambert RG
Ann Rheum Dis; 2018 Jan; 77(1):78-84. PubMed ID: 28970212
[TBL] [Abstract][Full Text] [Related]
2. MRI evidence of structural changes in the sacroiliac joints of patients with non-radiographic axial spondyloarthritis even in the absence of MRI inflammation.
Maksymowych WP; Wichuk S; Dougados M; Jones H; Szumski A; Bukowski JF; Marshall L; Lambert RG
Arthritis Res Ther; 2017 Jun; 19(1):126. PubMed ID: 28587658
[TBL] [Abstract][Full Text] [Related]
3. Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study.
Maksymowych WP; Dougados M; van der Heijde D; Sieper J; Braun J; Citera G; Van den Bosch F; Logeart I; Wajdula J; Jones H; Marshall L; Bonin R; Pedersen R; Vlahos B; Kotak S; Bukowski JF
Ann Rheum Dis; 2016 Jul; 75(7):1328-35. PubMed ID: 26269397
[TBL] [Abstract][Full Text] [Related]
4. Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis.
Maksymowych WP; Baraliakos X; Lambert RG; Landewé R; Sandoval D; Carlier H; Lisse J; Li X; Hojnik M; Østergaard M
Lancet Rheumatol; 2022 Sep; 4(9):e626-e634. PubMed ID: 38288892
[TBL] [Abstract][Full Text] [Related]
5. Course of Magnetic Resonance Imaging-Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double-Blind, Placebo-Controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by the Berlin and Spondyloarthritis Research Consortium of Canada Methods.
Pedersen SJ; Poddubnyy D; Sørensen IJ; Loft AG; Hindrup JS; Thamsborg G; Asmussen K; Hendricks O; Nørregaard J; Piil AD; Møller JM; Jurik AG; Balding L; Lambert RG; Sieper J; Østergaard M
Arthritis Rheumatol; 2016 Feb; 68(2):418-29. PubMed ID: 26414004
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of active inflammation, chronic structural damage, and response to treatment of sacroiliitis in axial spondyloarthritis using the Spondyloarthritis research consortium of Canada scoring system.
Zhang Y; Guo Z; Zhan Y; Qu J; Lei X
BMC Musculoskelet Disord; 2022 Jul; 23(1):654. PubMed ID: 35804360
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR cohort) in recent onset axial spondyloarthritis.
Dougados M; Maksymowych WP; Landewé RBM; Moltó A; Claudepierre P; de Hooge M; Lambert RG; Bonin R; Bukowski JF; Jones HE; Logeart I; Pedersen R; Szumski A; Vlahos B; van der Heijde D
Ann Rheum Dis; 2018 Feb; 77(2):221-227. PubMed ID: 28970213
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor inhibitor therapy but not standard therapy is associated with resolution of erosion in the sacroiliac joints of patients with axial spondyloarthritis.
Pedersen SJ; Wichuk S; Chiowchanwisawakit P; Lambert RG; Maksymowych WP
Arthritis Res Ther; 2014 Apr; 16(2):R100. PubMed ID: 24755322
[TBL] [Abstract][Full Text] [Related]
9. Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial.
van der Heijde D; Baraliakos X; Hermann KA; Landewé RBM; Machado PM; Maksymowych WP; Davies OR; de Peyrecave N; Hoepken B; Bauer L; Nurminen T; Braun J
Ann Rheum Dis; 2018 May; 77(5):699-705. PubMed ID: 29343510
[TBL] [Abstract][Full Text] [Related]
10. Erosions on T1-Weighted Magnetic Resonance Imaging Versus Radiography of Sacroiliac Joints in Recent-Onset Axial Spondyloarthritis: 2-Year Data (EMBARK Trial and DESIR Cohort).
Maksymowych WP; Claudepierre P; de Hooge M; Lambert RG; Landewé R; Molto A; van der Heijde D; Bukowski JF; Jones H; Pedersen R; Szumski A; Vlahos B; Dougados M
J Rheumatol; 2024 May; 51(5):462-471. PubMed ID: 38359938
[TBL] [Abstract][Full Text] [Related]
11. Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR.
Maksymowych WP; Claudepierre P; de Hooge M; Lambert RG; Landewé R; Molto A; van der Heijde D; Bukowski JF; Jones H; Pedersen R; Szumski A; Vlahos B; Dougados M
Arthritis Res Ther; 2021 Jan; 23(1):43. PubMed ID: 33514428
[TBL] [Abstract][Full Text] [Related]
12. Effects of Long-Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104-Week Results From a Randomized, Placebo-Controlled Study.
Dougados M; van der Heijde D; Sieper J; Braun J; Citera G; Lenaerts J; van den Bosch F; Wei JC; Pedersen R; Bonin R; Jones H; Marshall L; Logeart I; Vlahos B; Bukowski JF; Maksymowych WP
Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1590-1598. PubMed ID: 28482137
[TBL] [Abstract][Full Text] [Related]
13. Structural progression rate decreases over time on serial radiography and magnetic resonance imaging of sacroiliac joints and spine in a five-year follow-up study of patients with ankylosing spondylitis treated with tumour necrosis factor inhibitor.
Pedersen SJ; Weber U; Said-Nahal R; Sørensen IJ; Loft AG; Kollerup G; Juul L; Frandsen PB; Thamsborg G; Madsen OR; Møller J; Balding L; Jurik AG; Østergaard M
Scand J Rheumatol; 2019 May; 48(3):185-197. PubMed ID: 30422733
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of etanercept in patients from Latin America, Central Europe and Asia with early non-radiographic axial spondyloarthritis.
Wei JC; Tsai WC; Citera G; Kotak S; Llamado L
Int J Rheum Dis; 2018 Jul; 21(7):1443-1451. PubMed ID: 27863065
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).
Sieper J; van der Heijde D; Dougados M; Mease PJ; Maksymowych WP; Brown MA; Arora V; Pangan AL
Ann Rheum Dis; 2013 Jun; 72(6):815-22. PubMed ID: 22772328
[TBL] [Abstract][Full Text] [Related]
16. Development and preliminary validation of the spondyloarthritis research consortium of Canada magnetic resonance imaging sacroiliac joint structural score.
Maksymowych WP; Wichuk S; Chiowchanwisawakit P; Lambert RG; Pedersen SJ
J Rheumatol; 2015 Jan; 42(1):79-86. PubMed ID: 25320219
[TBL] [Abstract][Full Text] [Related]
17. Active Inflammatory and Chronic Structural Damages of Sacroiliac Joint in Patients With Radiographic Axial Spondyloarthritis and Non-Radiographic Axial Spondyloarthritis.
Tu L; Lin C; Xie Y; Wang X; Wei Q; Zhang Y; Gu J
Front Immunol; 2021; 12():700260. PubMed ID: 34386008
[TBL] [Abstract][Full Text] [Related]
18. Consistently Good clinical response in patients with early axial spondyloarthritis after 3 years of continuous treatment with etanercept: longterm data of the ESTHER trial.
Song IH; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Weiß A; Buß B; Freundlich B; Lange E; Alten R; Rudwaleit M; Sieper J
J Rheumatol; 2014 Oct; 41(10):2034-40. PubMed ID: 25028375
[TBL] [Abstract][Full Text] [Related]
19. Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial).
Maksymowych WP; Østergaard M; Landewé R; Barchuk W; Liu K; Tasset C; Gilles L; Hendrikx T; Besuyen R; Baraliakos X
Rheumatology (Oxford); 2022 May; 61(5):2063-2071. PubMed ID: 34352069
[TBL] [Abstract][Full Text] [Related]
20. Brief Report: Six-Week Treatment of Axial Spondyloarthritis Patients With an Optimal Dose of Nonsteroidal Antiinflammatory Drugs: Early Response to Treatment in Signal Intensity on Magnetic Resonance Imaging of the Sacroiliac Joints.
Varkas G; Jans L; Cypers H; Van Praet L; Carron P; Elewaut D; Van den Bosch F
Arthritis Rheumatol; 2016 Mar; 68(3):672-8. PubMed ID: 26473982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
